Milena Mitrovic

Novi Sad, VO, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Effects of glucagon-like peptide-1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials.

Effects of glucagon-like peptide-1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta-analysis of randomized controlled trials.

Journal: Diabetes, obesity & metabolism

Published: August 07, 2024

Effect of sodium-glucose cotransporter-2 inhibitors on continuous glucose monitoring metrics, as adjunctive to insulin in adults with type 1 diabetes mellitus: a meta-analysis of randomized controlled trials.

Effect of sodium-glucose cotransporter-2 inhibitors on continuous glucose monitoring metrics, as adjunctive to insulin in adults with type 1 diabetes mellitus: a meta-analysis of randomized controlled trials.

Journal: Metabolism: clinical and experimental

Published: November 03, 2023

Diffusion-weighted imaging in the assessment of renal function in patients with diabetes mellitus type 2.

Diffusion-weighted imaging in the assessment of renal function in patients with diabetes mellitus type 2.

Journal: Magma (New York, N.Y.)

Published: May 12, 2020

Fecal pancreatic elastase-1 and erythrocyte magnesium levels in diabetes type 1 and type 2.

Fecal pancreatic elastase-1 and erythrocyte magnesium levels in diabetes type 1 and type 2.

Journal: Magnesium research

Published: August 15, 2018

The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity.

The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity.

Journal: Current neurovascular research

Published: May 02, 2017

1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity.

1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity.

Journal: Endocrine, metabolic & immune disorders drug targets

Published: April 04, 2017

Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity.

Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity.

Journal: Current vascular pharmacology

Published: December 13, 2016

Circulating sclerostin levels and cardiovascular risk in obesity.

Circulating sclerostin levels and cardiovascular risk in obesity.

Journal: International journal of cardiology

Published: February 01, 2016

The impact of diabetes mellitus on the course and outcome of pregnancy during a 5-year follow-up.

The impact of diabetes mellitus on the course and outcome of pregnancy during a 5-year follow-up.

Journal: Vojnosanitetski pregled

Published: December 19, 2014

Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile.

Obesity and vitamin D deficiency: trends to promote a more proatherogenic cardiometabolic risk profile.

Journal: Angiology

Published: March 25, 2014

Influence of glucoregulation quality on C-reactive protein, interleukin-6 and tumor necrosis factor-alpha level in patients with diabetes type 1.

Influence of glucoregulation quality on C-reactive protein, interleukin-6 and tumor necrosis factor-alpha level in patients with diabetes type 1.

Journal: Vojnosanitetski pregled

Published: November 04, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026